The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects. Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute. The Paul-Ehrlich-Institut, with its more than 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.). www.pei.de/impress
View Top Employees from Paul-Ehrlich-InstitutWebsite | https://www.pei.de |
Revenue | $24 million |
Employees | 435 (330 on RocketReach) |
Technologies |
JavaScript,
HTML,
PHP
+5 more
(view full list)
|
Industry | Research Services, Business Services General, Biotechnology, Business Services, Science and Engineering |
Web Rank | 363262 |
Web Visits | 123980 |
Keywords | Pharmacovigilance, Life Science |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Paul-Ehrlich-Institut employee's phone or email?
The Paul-Ehrlich-Institut annual revenue was $24 million in 2024.
Zoltan Ivics is the Head of Research of Paul-Ehrlich-Institut.
330 people are employed at Paul-Ehrlich-Institut.
The NAICS codes for Paul-Ehrlich-Institut are [54, 5417, 541713, 54171, 541].
The SIC codes for Paul-Ehrlich-Institut are [873, 87].